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Resolving the mechanisms underlying human neuronal diversification remains a major challenge in developmental and applied
neurobiology. Motor neurons (MNs) represent a diverse pool of neuronal subtypes exhibiting differential vulnerability in different
human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). The ability
to predictably manipulate MN subtype lineage restriction from human pluripotent stem cells (PSCs) will form the essential basis
to establishing accurate, clinically relevant in vitro disease models. I first overview motor neuron developmental biology to provide
some context for reviewing recent studies interrogating pathways that influence the generation of MN diversity. I conclude that
motor neurogenesis from PSCs provides a powerful reductionist model system to gain insight into the developmental logic of
MN subtype diversification and serves more broadly as a leading exemplar of potential strategies to resolve the molecular basis of
neuronal subclass differentiation within the nervous system. These studies will in turn permit greater mechanistic understanding
of differential MN subtype vulnerability using in vitro human disease models.
1. Introduction
Human neurodegenerative disorders represent a spectrum of
progressive and untreatable clinical diseases, characterized
by selective loss of neurons, usually in a region-specific
(e.g., Parkinson’s disease) and/or subtype-specific (e.g., ALS)
fashion. There is a great experimental need for renewable
sources of clinically relevant, region-specific, and subtype-
specific neurons. Lineage restriction and the generation
of neuronal diversity within the developing neuraxis are
consequences of the interplay of multiple developmental
signals, which are regulated in a spatiotemporal manner.
Precise cellular and molecular mechanisms through which
these complex sequential and progressive developmental
processes are orchestrated remain unresolved. The ability
to generate defined neuronal cell types from PSCs offers a
unique experimental opportunity to study the developmental
mechanism(s) underlying generation of neural diversity dur-
ing human embryogenesis [1, 2] (Figure 1). In turn, this will
permit more accurate directed differentiation of regionally
defined neurons for disease modeling, drug discovery, and
potentially cell-based neural repair strategies.
Although often considered collectively as a group, neu-
rons within an organism comprise highly diverse units
differing in their gene expression profile, morphology, con-
nectivity, functional characteristics, and response to injury
or disease. Neuronal subtypes also differ markedly in devel-
opmental origin and anatomical location (Figure 1). Under-
standing how neuronal subtype diversity is accomplished
within the developing neuraxis remains a major challenge in
developmental neurobiology. Elucidating the transcriptional
“logic” of cell fate specification is of equal relevance to the
emerging discipline of regenerative neurology. The intercon-
nectedness of developmental neurobiology and regenerative
neurology is evident from global research efforts attempting
to generate enriched populations of regionally defined and
clinically relevant neuronal subtypes from PSCs. Such strate-
gies for directed differentiation require an understanding of
the embryonic origins of the neuronal subtype in question,
allowing one to model neurodegenerative disease in vitro
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Figure 1: A simplified depiction of vertebrate nervous system regional organization (image of fetus adapted from [4]).
with fidelity and precision [3]. The fact that clinical neu-
rodegenerative disease classically occurs in a region-specific
and/or subtype-specific manner reinforces the importance of
this line of enquiry. Selective vulnerability of individual sub-
types of neurons underlies the majority of such progressive
and incurable conditions. Against this background, spinal
cordMNs provide a clinically relevant, prototypic example of
cell fate specification, for which animal studies have already
begun to elucidate the molecular basis of lineage restriction
at specific developmental phases.
2. Motor Neuron Developmental Biology
Motor neuron specification requires several sequential devel-
opmental steps including neural induction from embryonic
ectoderm, patterning along rostrocaudal and dorsoventral
axes, and subsequently the terminal differentiation of region-
ally specified neural precursors into postmitotic neuronal
subtypes. Following neural induction, precursors default
to a rostral and dorsal positional identity through the
combined actions of the BMP, WNT, and FGF signaling
pathways, which have unique spatiotemporal influences on
regional identity and cell fate [5–7]. Signaling pathways that
operate along the rostrocaudal and dorsoventral neuraxes
first establish a matrix of positional cues, which influence
precursor cell fate specification by regulating the identities
and concentrations of morphogenetic signals to which they
are subjected [8].
2.1. Rostrocaudal (R-C) Patterning. Caudalizing morphogens
respecify the positional identity of neurogenic precursors
largely through their influence on the Hox genes, which
are a family of transcription factors that regulate acquisition
of positional identity in individual segments of the spinal
cord [9, 10]. Hox genes contain a DNA sequence known as
the “homeobox” and are further codified by their specific
location in gene clusters within the genome, exhibiting R-C
expression pattern that reflects their relative location within
the gene cluster. Graded fibroblast growth factor (FGF) sig-
naling functions along the R-C axis to induce the expression
of chromosomally linked Hox genes in the neural tube. Hox
genes located at one end of the cluster (3󸀠 end) are expressed
more rostrally in response to low levels of FGF; conversely,
genes at the opposite end (5󸀠 end) are expressed caudally
in response to high levels of FGF. Different Hox “paralog”
genes are consequently expressed at brachial (Hox4–Hox8),
thoracic (Hox8-Hox9), and lumbar (Hox10–Hox13) levels of
the spinal cord [11–13] (Figure 2). Body segmentation studies
originated from work on the development of Drosophila
body plan. In addition to determining the basic structure
and orientation of an organism, Hox proteins also have a
crucial role in determining the subtype diversification of
MNs and their peripheralmuscle target connectivity [14].The
mechanisms by which a Hox-based transcriptional network
choreographs these processes are beginning to be resolved
[15]. Retinoic acid (RA) and FGF signaling influence Hox
expression in spinal cord neural precursors. Graded FGF
signals regulate the primary Hox expression pattern before
further superimposed cues refine subset-specific Hox gene
expression. Rostrally, RA regulates Hox expression at cervi-
cal/brachial levels in part by antagonizing the FGF gradient
[12, 16]. Caudally, Gdf11 (a member of TGF-𝛽 family) plays a
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Figure 2: A schematic depicting expression patterns of chromosomally linked Hox genes along the rostrocaudal axis. Hox genes at one
end of the cluster are expressed more rostrally, while those at the opposite end are expressed caudally. As indicated, RA is responsible
for rostral spinal cord patterning (i.e., the cervical spinal cord). Caudal spinal areas are patterned by FGFs and GDFs. The precise nature
of how these caudalizing factors conspire with one another has yet to be resolved. RA: retinoic acid; FGF: fibroblast growth factor; GDF:
growth/differentiation factor.
critical role in Hox8–Hox10 gene expression at thoracic and
lumbar spinal cord levels (Figure 2) [17, 18]. Themechanisms
that translate graded signals into R-C positional information
within the spinal cord remain largely unresolved. Indeed the
temporal delay between Hox gene transcription and mRNA
translation also remains elusive but this phenomenonmay be
at least partially accounted for by microRNA posttranscrip-
tional regulation [19].
2.2. Dorsoventral (D-V) Patterning. During spinal cord devel-
opment, several distinct neuronal subtypes are generated
by the interaction of opposing morphogenetic gradients
along the D-V axis of the neural tube, which establish
a matrix of positional identities that in turn permit dis-
crete precursor domains to emerge (Figure 3). This process
underlies motor neurogenesis and ventral interneurogenesis
[8]. Each neuronal group arises from discrete regions or
“precursor domains” that are anatomically positioned in a
stereotyped D-V arrangement. Ventral neuronal patterning
results from morphogenetic cues emanating from a group
of cells positioned at the ventral midline of the neural tube
(called the floor plate) and the notochord [20]. In the early
90s, several labs successfully cloned vertebrate homologues
of the Drosophila gene Hedgehog, which encodes secreted
signaling proteins [21–24]. Sonic Hedgehog (Shh) was later
discovered to be the ventrally secreted morphogenetic cue
that confersD-Vpolarity to the ventral neural tube. Addition-
ally, early experimental data suggested that Shh function was
concentration-dependent [25]. Shh is a secreted glycoprotein
expressed by the notochord and later by the floor plate,
likely secondary to autoinduction [24, 26]. Motor neuron
generation depends on two critical temporally distinct phases
of Shh signaling: an early period, where it induces neural
plate precursor cells to become ventralized, and a late period,
where Shh drives the differentiation of ventralized precursors
into motor neurons, at which point there is a concentration-
dependent specification of ventral precursors into motor
neurons or interneurons [27]. Antibodies against Shh inhibit
motor neurogenesis in neural plate explants, despite the
normal induction of floor plate cells under these conditions
[25]. Key studies using animal explant cultures have defined
important roles for Shh in floor plate specification, motor
neurogenesis, and ventral spinal cord interneurogenesis [27].
These studies suggest that neural precursor cells require
early exposure to Shh derived from the notochord soon
after neural plate formation to permit competence for motor
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Figure 3: “Patterning” principles of the ventral neural tube by graded Sonic Hedgehog (Shh) signaling. Shh, shown in red, originates in the
notochord (N) and floor plate (FP) and establishes a matrix of concentration-dependent positional identities, which are defined by particular
combinatorial profiles of homeodomain transcription (HD) factors and basic helix-loop-helix (bHLH) transcription factors. Discrete ventral
precursor domains are established by Shh-regulated transcription factor expression and divided into class I and class II factors based on
their mode of regulation by Shh.These transcription factors are intermediaries in Shh-dependent ventral neural patterning. Cross-repressive
interactions between class I and class II factors contribute to establishing individual precursor domains (P0–P3) with distinct boundaries as
depicted. Each precursor domain gives rise to a specific class of postmitotic neurons. The cross-repressive class II factor counteracting Pax7
remains unresolved. Motor neurons are generated from the pMN domain.
neurogenesis (Figure 3). The downregulation of Pax7 and
Pax3 by neural plate cells temporally coincides with their
competence to generate ventral cell types [28, 29]. The
second and late critical period for Shh signaling in motor
neurogenesis occurs after ventralization of precursors. In
vitro studies using animal explants show that ventralized
precursors deprived of Shh signaling cannot generate motor
neurons [27]. Ventralized motor neuron precursors require
Shh well into S phase of the final division cycle. The late
dependence on Shh suggests that motor neuron identity
is determined within late S phase of the final precursor
cell division, consistent with studies addressing mammalian
cortical laminar determination [30].
Shh signaling therefore determines neuronal subtype
identity during the final division of ventral precursor cells,
with higher concentrations promoting motor neuron spec-
ification and lower concentrations diverting cell fate to
Lim1/Lim2 expressing interneurons [27].The extent to which
this implicates a common precursor has yet to be resolved.
These studies show that the Shh concentration required to
permit competence of neural plate cells formotor neurogene-
sis is 3 times lower than the concentration for the specification
of motor neuron fate at a later stage. Furthermore, the Shh
concentration for floor plate specification is 3 times greater
than that for motor neuron generation [26]. Taken together,
this suggests that different Shh concentrations operate at
sequential periods during the generation of a single neuronal
cell type and support the more generic concept that Shh
controls the identity and pattern of ventral neural tube cell
types by actions at multiple concentration thresholds.
The absolute requirement for Shh in floor plate and
motor neuron differentiation, however, remains unresolved.
Shh secreted from the notochord might therefore control
patterning in the ventral neural tube entirely through local
signaling, with long-range influences mediated by a sec-
ondary diffusible factor. Indeed, many of the long-range
patterning activities of Hedgehog in Drosophila depend on
the induction of diffusible intermediary factors, notably
the transforming growth factor-𝛽- (TGF-𝛽-) like protein
Decapentaplegic (DPP) [31, 32]. The necessity of Shh for
motor neurogenesis and ventral interneurogenesis in vivo is
supported by loss-of-function studies [27, 33]. Experiments
using explants of naive neural tissue confirmed that varying
concentrations of Shh protein specified distinct neuronal
subtypes [34, 35].
These studies raise the issue of how positional identity is
imposed on precursor cells and how this determines neuronal
subtype identity. Several studies have suggested that a group
of transcription factors, predominantly the homeodomain
(HD) factors, are critical intermediaries in the process [34–
37]. These transcription factors are expressed in stereotypic
patterns along the D-V axis of the neural tube. Determined
by their mode of regulation in response to Shh signaling,
individual factors are designated as class I or II proteins.
Class I proteins are repressed at particular concentrations
of Shh, which thus defines their ventral limit of expression.
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Conversely, class II protein expression is induced by Shh,
which therefore defines dorsal boundaries of their expression.
Combinatorial expression of both classes of protein allows the
establishment of five ventral neural tube precursor domains,
which in turn permit the specification of distinct neuronal
subtypes (Figure 3). The profile of HD protein expression
thus appears to represent a transcriptional code that allo-
cates positional identity to precursors, enabling differential
neuronal subtype specification. Subsequent gain- and loss-
of-function experiments in chick and mouse embryos have
indeed provided further support for this putative mecha-
nism, where ectopic expression of HD proteins predictably
changed the position in which individual neuronal sub-
types were generated in the neural tube [34–39]. Selective
cross-repressive interactions between pairs of class I and
II proteins expressed in adjacent precursor domains have
since emerged as an important feature in the developmental
logic of ventral spinal neurogenesis [34–37]. This principle
of cross-repressive interactions observed in the neural tube
is reminiscent of mechanisms involved in R-C patterning
of the Drosophila embryo [40]. This raises the possibility
that such processes may represent a more generic strategy
underpinning the developmental logic for regional allocation
of cell fate in response to morphogenetic instruction.
As described above, MNs originate from highly restricted
foci in the ventral neural tube (pMN domain) in response
to the morphogen Shh. In turn, Shh induces upregulation of
the basic helix-loop-helix (bHLH) transcription factor Olig2,
which then associates with another bHLH transcription
factor, neurogenin2 (Ngn2), to direct the expression of MN
fate consolidating genes such as Hb9 and Islet1 (Isl1) [41].
Olig2 is necessary for specification of MNs and, later in
development, oligodendrocyte precursors. MN precursors
are characterized by a particular “signature” of HD proteins
and bHLH transcription factors including Pax6 and Olig2 as
depicted in Figure 3 [34]. Each of these factors has a distinct
role in MN specification. Pax6, for example, is involved
in the establishment of discrete precursor domains in the
ventral spinal cord and regulates cell fate specification of both
motor neurons and interneurons via graded Shh signaling
[35]. The combinatorial action of these HD proteins and
bHLH transcription factors directs precursors to a terminally
differentiated postmitotic state, after which they begin to
upregulate fate consolidating downstream genes such as
Hb9 [42–44]. The pMN domain precursors exclude Pax7,
Irx3, and Nkx2.2 (Figure 3). If Shh is not administered in
conjunction with RA, the resulting precursors fail to express
pMN domain markers as they contain a mixed (dorsal to
ventral) array of spinal cord regional identities.The degree to
which precursors are ventralized in the spinal cord, which is
dependent on the concentration of Shh used, is critical to cell
fate determination and can be discriminated based on HD
and bHLH factor expression profiles.
2.3. Motor Columns and Subtypes. MN subclasses are further
organized into groups that reflect both their developmental
origins and also their adult function. Specifically, MNs are
developmentally allocated to discrete motor columns, which
extend along theR-Cneural tube.Within a column, the group
of MNs responsible for innervating a single skeletal muscle is
termed a motor pool, each of which is also arranged by an
anatomical logic corresponding to the muscle target(s) of its
projections.Themedialmotor column (MMC) containsMNs
that innervate dorsal epaxial muscles, which mainly subserve
postural functions. MNs of hypaxial motor column (HMC)
project to the ventral hypaxial muscles, which are involved in
respiration. The lateral motor columns (LMCs) are respon-
sible for innervating limb muscles. The preganglionic motor
column (PGC) is present at thoracic levels and innervates
sympathetic ganglia. The MMCs run throughout the R-C
extent of the spinal cord, while the LMCs, HMCs, and PGCs
occur only at brachiolumbar (LMCs) and thoracic (HMCs
and PGCs) foci (Figure 4).
The molecular effectors that integrate morphogenetic
extrinsic signals with transcription factor expression/
repression to regulate neuronal subtype determination have
been extensively studied in vivo [45–47]. Retinoid signaling
plays key roles in the diversification ofMN subtypes from the
common MN precursor pool and additionally contributes
to spinal cord columnar organization. These distinct
MN subtypes can be discriminated based upon their gene
expression profiles [48, 49]. At brachiolumbar foci, within the
LMCs, RA is synthesized locally by subpopulations of MNs
expressing RALDH2 and specifies migrating precursors into
a distinct subset of LMC MNs (i.e., the lateral LMC MNs).
The role of retinoid signaling in MN subtype specification
has been demonstrated using heterotopic transplantation
of RA synthesis “hotspots” (brachial and lumbar neural
tube/somites) with subsequent characterization of regional
MN subtype [50]. Additionally, ectopic RALDH2 expression
in spinal neurons generates LMCMNs and RALDH2 knock-
down and knock-out studies yield a reduction of both lateral
and medial LMC neurons [49, 51]. These in vivo experiments
also demonstrated marked depletion of dorsomedially posi-
tioned Isl+ preganglionic autonomic MNs (termed Column
of Terni (CT) neurons in the chick [52]) upon expression
of a constitutively active retinoid receptor in postmitotic
MNs [49]. A significant reduction in ventrally positioned
Isl1/2+, Lim3− lateral MMC-like MNs was also found under
these conditions [49]. However, inhibition of RA signaling in
brachial motor neurons did not promote the differentiation
of medial MMC neurons [49]. Interestingly, previous in vivo
studies have demonstrated a regionally restricted role for
retinoid signaling in the postmitotic specification of motor
neuronal columnar identity [53, 54]. It is likely that the
developmental programmes determining specification of
distinct subtypes of MN require extrinsic morphogenetic
instruction during both precursor specification and terminal
differentiation. These studies illustrate the distinct require-
ments for RA signaling in MN generation and organization.
There is an unambiguous relationship between Hox
protein expression and MN subtype determination. Specif-
ically, Hox6 expression occurs in brachial LMC neurons,
Hox9 proteins are expressed in thoracic PGC neurons, and
Hox10 proteins are characteristically expressed by lumbar
LMC neurons (Figure 2) [12, 13]. Cross-repressive, regu-
latory interactions occurring between these Hox proteins
further refine expression profiles and facilitate MN subtype
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Figure 4: A schematic depicting columnar arrangement of motor neuron subtypes in relation to different rostrocaudal portions of the
neuraxis. The LMCs exist only at cervical (brachial) and lumbar foci and are responsible for innervating the muscles of the upper and
lower limbs, respectively. The MMC exists throughout the rostrocaudal extent of the spinal cord and is responsible for innervating axial
musculature.TheHMC and PGC exist only in thoracic portions of the spinal cord and innervate the intercostal musculature and sympathetic
ganglia, respectively. R-C: rostrocaudal; LMC: lateral motor column; MMC: medial motor column; HMC: hypaxial motor column; PGC:
preganglionic motor column; MN: motor neuron.
diversification. Misexpression experiments have suggested
that Hox protein expression is sufficient to direct changes in
MN columnar identity [13, 55]. The emerging logic of Hox
functions along the R-C axis is reminiscent of mechanisms
regulating D-V patterning (discussed above). In both cases,
morphogenetic cues establish zones of homeodomain (HD)
protein expression with subsequent domain refinement via
selective cross-repressive interactions. Transcriptional cross-
repressive programmes operate at temporally discrete stages
of neurogenesis in each axis; they occur within neural pre-
cursor cells in the D-V axis [36] and in postmitotic neurons
in the R-C axis [13]. The precise choreography of these
sequential processes enables confinement of specific Hox
codes to postmitotic MNs. Although hierarchical patterns
in Hox expression have been posited in particular contexts
[56], this does not appear to be a generic regulatory principle
of Hox function [57, 58]. Functional dominances in Hox
expression are likely spatiotemporally determined.
Experiments involving intercolumnar fate switching have
demonstrated a consequent and congruent change in axonal
trajection. For example, ectopic expression of Hoxc10 (lum-
bar) at thoracic levels causes a fate change to LMC MNs,
which then project into the lower limb [55]. These experi-
ments and others show similar results using Hoxc6 ectopic
expression [59], thus confirming an additional role of Hox
proteins in regulating peripheral connectivity ofMNs to their
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targets. Although Hox proteins clearly have a critical role in
MN subtype diversification, there is accumulating evidence
that additional factors are necessary to refine their functions.
Recognition of broadHox expression throughout the embryo
and developing CNS, combined with the observation that the
same Hox protein is often expressed by multiple neuronal
types within a given spinal cord segment, argues for the
presence of additional regulatory factors. The existence of a
hierarchy of Hox regulatory factors, including both generic
and cell-type specific regulators, is supported by several lines
of evidence [59–64]. A critical Hox cofactor regulating MN
subtype diversity that has emerged from these studies is
Foxp1, which appears to control columnar fate depending
on its level of expression within individual MNs [14]. The
function of Foxp1 has definitively been shown to be necessary
for specification of both the LMC and PGC MN columns
by genetic inactivation studies [14, 65]. Studies have also
demonstrated that extrinsic signaling postmitotically is a key
determinant of neuronal subtype diversification [8, 53, 54].
By utilizing a promoter that directs transgene expression to
postmitotic neurons, the timing of retinoid mediated MN
subtype diversification has been studied [42, 54]. Such exper-
iments definitively show that MN subtype identity remains
plastic after cell cycle exit [49]. Experimental alteration of
HD proteins within postmitotic MNs has also been shown to
result in subtype switching [54].
Against the background of these studies, it is clear that
the descriptive term “MN” is an oversimplification and the
numerous motor neuronal subtype differences described
above (including R-C position, column, pool, and axonal
trajection) begin to demonstrate some of the necessary com-
plexity inherent in MN diversification. The developmental
biology that underpins MN differentiation is relatively well
understood and thus provides a rational basis for using
human stem cell-based systems to allow further elucidation
of mechanisms responsible for generatingMN subtype diver-
sity.
3. Pluripotent Stem Cells
There are different sources of species-specific stem cells
including embryonic, fetal, and adult varieties. Embryonic
stem cells (ESCs) are a type of PSC thus possessing the
greatest developmental potential in vitro. PSCs respond
predictably to developmental cues such that their fate can
be systematically manipulated to differentiate into myriad
cell lineages from any of the 3 germ layers. There are 3
principal properties that characterize PSCs: (i) the ability
to self-renew, (ii) pluripotency (i.e., the ability to specialize
into any of the cell types that comprise the organism from
which they are derived) [66], and (iii) chimera formation.
Optimization of appropriate in vitro culture conditions for
the propagation of undifferentiated vertebrate tumor cell lines
in the 1970s [67] heralded the isolation ofmouse ESCs in 1981.
The key role of leukemia inhibitory factor in maintaining
pluripotency was later demonstrated [68]. Human ESCs were
first isolated in 1998 [69], some 17 years after the isolation of
mouse ESCs [70]. Human ESCs are isolated from the inner
cell mass of a preimplantation embryo, from where cells are
micromanipulated and subsequently grown in culture by a
variety of standardized methods [71–73]. Human ESCs can
be reliably identified by the expression of well characterized
transcription factors and surface antigens [74]. It is notewor-
thy that the blastocysts from which human ESCs are derived
exist in surplus and are donated to research by individuals
under fully informed consent at in vitro fertilization clinics
[75–77]. Establishment of optimal culture systems for mouse
ESCs guided human PSC culture techniques. However, sig-
nificant differences exist including the signaling pathways
required for maintaining pluripotency, FGF, Activin/Nodal,
and WNT being more important in human PSCs than
their mouse counterparts [78–80]. Feeder-free human PSC
culture systems, among several other innovations to the
culture constituents, have provided optimism for establishing
clinical-grade cells for use in regenerative medicine [73].
These refinements have somewhat addressed early concerns
around potential xenoinfection [81].
Compared to PSCs, stem cells isolated at later devel-
opmental stages possess a restricted phenotypic potential
that is tissue specific. Regional restriction (e.g., forebrain
versus spinal precursors) also represents a potential problem
because this cannot, at present, be predictably altered using
extrinsic signals. This tissue specific “multipotency” (i.e.,
the ability to differentiate into some but not all cell types
that comprise an organism) is a relative disadvantage when
studying cell fate specification, where the pluripotent state
represents an ideal investigative tool. Attempts to derive PSCs
by different methods have partially tempered the ethical
controversy in which the human ESC field is immersed [82].
These efforts were largely inspired by earlier seminal work
from Gurdon and Wilmut [83, 84] and focus on nuclear
reprogramming by somatic cell nuclear transfer (SCNT) and
cell fusion techniques [85]. Both methods, however, have
significant drawbacks: the requirement of oocytes in the
former and tetraploidy in the latter. Subsequent efforts have
also achieved ESC derivation from single blastomeres [86].
This area of research culminated in the discovery of induced
pluripotent stem cells (iPSCs), where adult somatic cells
are reprogrammed to embryonic-like stem cells by the viral
transduction of four transcription factors [87]. Other studies
have also achieved transcriptional or “forward” programming
where precursor cells are essentially converted to a desired
cell type using defined factors [88]. A further significant
advance that has been made is that of “transdifferentiation”
of one differentiated cell type into another. One such study
reprogrammed fibroblasts directly into functional neurons
[89] using defined virally transduced genes. Indeed, another
recent report describes the direct conversion of mouse and
human fibroblasts into functional and regionally defined
dopaminergic neurons [90]. These discoveries represent a
paradigm shift in the current thinking of lineage restriction.
4. Directed Differentiation of PSCs to
Motor Neurons
Predictable and scalable directed differentiation of PSCs to
the neural lineage is necessary for studying human neural
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development, modeling disease, and drug discovery. Several
well established methods can robustly achieve neural con-
version of PSCs in chemically defined conditions [91–98].
Efficient neural conversion in chemically defined medium is
based on the default model of neurogenesis [99, 100] where
extrinsic and intrinsic signals that could divert differentiation
to alternate fates are minimized in culture. Inhibition of
Activin/Nodal signaling accelerates neural conversion from
PSCs [101] and additionally imposes a caudal positional
identity on resulting precursors [102]. Inhibition of both the
Activin/Nodal and BMP arms of the TGF-𝛽 signaling super-
family permits highly efficient neural conversion of PSCs and
represents themost widely adoptedmethod employed to date
[92].
The elucidation of developmental inductive cues and
transcriptional programmes for MN specification [8] have
been instrumental in the directed differentiation of PSCs.
By recapitulating a developmentally rationalized programme
of morphogenetic cues, reproducible MN differentiation has
been demonstrated from mESCs [103] and human ESCs
[1]. Such studies confirm the expression of MN associated
transcription factors including Isl1 and Hb9. The detection
of specific enzymes/transporters including choline acetyl-
transferase (ChAT) and the vesicular acetylcholine neuro-
transmitter transporter (vAChT) provides further valida-
tion. Additionally, we and others have employed coculture
methods with myotubes to demonstrate the formation of
physiologically relevant neuromuscular junctions by human
PSC-derived spinal MNs [1, 104, 105]. Importantly, elec-
trophysiological studies confirm that motor neurons dif-
ferentiated from mESCs (and later human PSCs) acquire
appropriate functional properties [104]. Furthermore, these
motor neuron precursors survive and integrate in rodent
embryonic spinal cord [103, 106] and extend axons forming
physiologically relevant synapses. Functional engraftment
has also recently been demonstrated following peripheral
motor nerve transection [104]. Taken together, these studies
convincingly demonstrate functional motor neurogenesis
from human PSCs.
Insights from developmental studies across different
species and from in vitro work using human PSCs suggest
that, soon after neural induction, precursors initially assume
a rostral and dorsal positional identity through the combined
actions of the BMP, WNT, and FGF signaling pathways,
which have unique spatiotemporal influences on positional
identity and cell fate decisions [5, 6]. Mouse and human
PSC-derived neural precursors can differentiate into MNs
by application of a programme of extrinsic signals (FGF-2,
retinoic acid, and Sonic Hedgehog (Shh)) that recapitulate
the developmental process of neural patterning (discussed
above) in vitro [1, 103]. Once neural precursors have been
positionally specified to the ventral spinal cord, they can
be plated down for terminal differentiation. This usually
involves a poly-D-lysine/laminin substrate with concomitant
withdrawal of mitogens and addition of neurotrophic factors.
Using this approach in an adherent culture system, Olig2
precursors first appear at 2-3 weeks and markers of mature
MNs (such as HB9) appear at 4-5 weeks [1].
Important future studies would include systematic
analyses of the requisite time for neural patterning prior
to terminal differentiation, which has yet to be definitively
addressed. Some studies have suggested that accelerated
neural conversion and patterning protocols are possible. The
question of sequential versus simultaneous administration
of morphogenetic signals is another interesting subject,
which merits discussion here. In the case of motor neurons,
for example, the first directed differentiation of MNs from
mouse ESCs employed simultaneous administration of
RA and Shh [103], whereas when this was first achieved
in human PSCs [1] the cues were introduced sequentially
(RA before Shh). Given the complex spatiotemporal
regulation and reiterative use of such canonical signaling
pathways during embryogenesis, their individual and
combinatorial applications at both earlier and later time
points of currently established differentiation protocols are
worthy of consideration. Such studies will help to uncover
mechanisms underlying the generation of neuronal diversity
by more closely approximating in vivomotor neuron lineage
restriction.
5. Generating Diverse MN Subtypes from
Human PSCs
There is an increasing wealth of literature around the mecha-
nisms underlying neurodevelopment, revealing a remarkable
and previously unrecognized extent of neuronal diversity.
Functionally relevant differences in molecular phenotype,
axonal projection, dendritic arborization, and electrophysio-
logical attributes have been demonstrated between different
neuronal subtypes throughout the neuraxis [107–110]. The
ability to generate defined cellular subtypes from human
PSCs through application of neurodevelopmental principles
offers a unique experimental opportunity to interrogate the
molecularmechanisms underlying human neuronal diversity
[1, 2].
To date, the vast majority of studies using ESCs have
focused on deriving MNs generically, while comparatively
few studies address the issue of motor neuronal subtype
diversification. Most protocols for motor neuron specifica-
tion from PSCs (either ESCs or iPSCs) utilize the application
of a simplistic programme of morphogenetic signals to
achieve neural patterning, followed by standard terminal
differentiation conditions. Signaling mechanisms and tran-
scriptional events involved in the postmitotic diversification
of motor neuronal subtypes from human ESCs remain
poorly characterized. Currently, no study has systematically
investigated the influence of a morphogenetic signal during
bothMN precursor “patterning” and terminal differentiation
in order to establish their relative contributions to subtype
choice during these distinct developmental stages.
MNs are a diverse collection of neuronal subtypes dis-
playing differential vulnerability in different human neurode-
generative diseases. During embryogenesis, retinoid signal-
ing contributes to caudal precursor specification generically
and subsequent MN subtype diversification. RA typically
results in a cervical or brachial positional identity [105, 106].
Stem Cells International 9
Against this background, we reported a retinoid independent
strategy for generating MNs from human PSCs that yields
a predominantly caudal (lumbar spinal) MN identity and
bias to the MMC (both lateral and medial subdivisions)
[105]. Recognition that subclasses of MNs can be specified
independently of RA in the context of Activin/Nodal inhibi-
tion and Hedgehog signaling increases the potential diversity
of human motor neurons for study. More caudal MN fates
can be achieved in the absence of RA signaling (possibly
in response to FGF2). In addition, RA-independent motor
neurogenesis results in a MMC subtype bias compatible with
the known contribution of RA to subtype determination
[50]. Recent evidence suggests a role for Hoxc9 as a “master
regulator” of motor system organization through global
cross-repressive activities [15]. Indeed our own data suggest
significantly more induction of Hoxc9 in RA-treated when
compared to RA-independent cultures (although expression
is evident in both conditions). Further manipulation of
Hoxc9 expression, via extrinsic signals or gene targeting, may
facilitate more refined approaches to directed differentiation
of human PSCs to enriched populations of motor neuronal
subtypes. Foxp1 (high) (LMC) human PSC-MNs are specified
with continued retinoid exposure, while inhibition of this
pathway in MNs is shown to divert LMC subtype to a
lateral MMC (or HMC) identity, consistent with previous
developmental in vivo studies [48]. Therefore, these findings
support a model whereby retinoid signaling promotes the
specification of LMC MNs at the expense of lateral MMC
MNs. Furthermore, the refractoriness of the medial MMC
to changes in retinoid signaling implicates its development
as a motor neuronal “ground state.” This retinoid-mediated
diversification of motor neuron subtypes was also supported
by a contemporaneous study using mouse ESCs [106]. Sepa-
rately, a recent report described combining retinoic acid and a
WNT agonist to generate cranial motor neurons from human
PSCs [111]. Collectively, these studies support the view that
the retinoid pathway plays key roles in subtype determination
within the MN pool [48, 49, 111–113]. More subtle methods
of generating MN subtype diversity include manipulating
the concentration or chemical composition of extrinsic cues.
This strategy was recently employed by a study substitut-
ing recombinant Shh for SAG (a chlorobenzothiophene-
containing Shh pathway agonist) and purmorphamine [114]
(a small-molecule agonist for Smoothened) in combination,
with consequent subtype variation ofMMCversus LMCMNs
[115].
Separately, the use of suspension culture [102, 105, 106, 115,
116] versus adherent culture methods [92, 117] by different
groups will likely have a significant impact on the subtype
diversity of MNs generated and requires further study. Tran-
scriptional or “forward” programming approaches [118], in
addition to improving the efficiency and timing of directed
differentiation of PSCs, have also yielded some relevant
insights into mechanisms underlying MN subtype deter-
mination. In mouse ESCs, three transcriptional (forward
programming) factors, Ngn2, Isl1, and Lhx3, were sufficient
to specify spinalMN identity. In this study, replacing the Lhx3
programming factor with Phox2a yielded cranial rather than
spinal MNs [119]. Transdifferentiation [89] approaches have
also successfully generated MNs from human PSCs [120],
providing an ideal “test-bed” for elucidating the transcrip-
tional logic of MN subtype determination. The functional
implications of these studies are of considerable interest
because motor column organization in development forms
the basis for motor pools and target innervation [121].
Furthermore, in diseases such as ALS, MN subtypes exhibit
differential vulnerability to degeneration.
6. Conclusions
Elucidating efficient protocols to generate enriched popula-
tions of MN subtypes has important biotechnological impli-
cations for disease modeling, drug discovery, and potentially
cell-based therapy. Such approaches would permit com-
prehensive mechanistic studies of differential MN subtype
vulnerability in vitro.Access to human PSCs allows questions
around early cell fate acquisition to be addressed. Devel-
opmental competence to extrinsic morphogenetic signals
during embryonic patterning is both spatially and temporally
restricted. Human PSCs faithfully recapitulate the key mile-
stones of neurodevelopment and thus permit studies that will
improve our understanding of the relative contributions of
extrinsic signals, cell-intrinsic transcriptional programmes,
and intercellular/paracrine communication to direct cell fate
decisions. This reductionist model system, together with the
use of a fully defined cell culture medium, provides a unique
experimental opportunity to understand the relevance of
how signaling pathways function individually or combinato-
rially to direct lineage restriction at different developmental
stages. In turn, such knowledge will permit more predictable
manipulation of PSCs to generate desired progeny for exper-
imental study. PSCs therefore represent an unparalleled
opportunity to study human neurodevelopmental processes.
It is likely that, for future strategies aimed at generating
distinct subtypes of MN, controlled extrinsic morphogenetic
instruction during both precursor specification and terminal
differentiation will be key determinants of success. As a final
remark, although there is a considerable degree of conser-
vation in neuraxial systems between rodents and humans,
important differences in architecture, computational power,
and functional capacity exist. Such evolutionary divergence
strongly reinforces the indispensability of human experimen-
tal systems to complement, but not replace, existing rodent-
based approaches.
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